Background: Type 2 diabetes mellitus (T2DM) is a public health issue associated with a high prevalence of disability. Studies on disability profile in terms of reduction in body structure and function, personal activities and societal participation, defined as 'global disability', are scarce among people living with T2DM in Nigeria. Objectives: To assess the prevalence of global disability and its predictors among Nigerian living with T2DM. Methods: A cross-sectional analysis of 162 patients diagnosed with T2DM and attending a tertiary health facility was performed for global disability measure and function. Their clinical and socio-demographic data were obtained. Poisson regression analysis was applied to assess the predicting factors of disability. Results: A mean global disability score of 22.1 was reported among the participants, varying from moderate to high in each item. About 25.0% had mild disability, while 60.5% reported moderate to severe disability. Elevated glycosylated haemoglobin, fasting blood glucose, systolic blood pressure, age, disease duration and marital status predicted disability. A unit increase in HbA1c, systolic blood pressure and 1 month increase in DM duration had more disability reported estimates [1.062 (CI=1.050-1.075), 1.005 (CI=1.002-1.007) and 1.001 (CI=1.000-1.002) times, respectively]. Married participants were 1.13 (CI=1.02-1.23) times more likely to be disabled than unmarried. Conclusions: There is mild to moderate burden and risk of global disability among Nigerian living with T2DM. Age, DM duration, marital status, fasting blood glucose, glycosylated haemoglobin and systolic hypertension significantly predicted disability.
INTRODUCTION
Type-2 diabetes mellitus (T2DM) is a global public health issue with increased prevalence affecting about 415 million people (8.8% of adults aged 20-79 years in 2015) of which 75.0% live in low-and middle-income countries. 1 If this trend continues, about 642 million people or one in 10 adults will have T2DM by 2040. 1 In Nigeria, there is increasing burden of T2DM; many persons are currently undiagnosed with few of the known cases on treatment. 2 A recent review of prevalence rate of T2DM and conditions of dysglycaemia in Nigeria revealed impaired glucose tolerance at 10.0% and impaired fasting glucose at 5.8% with 4.7 million Nigerians living with T2DM, suggesting < 10.0% national prevalence rate. 2, 3 Furthermore, demographic, epidemiological and nutritional transitions in Nigeria in the past decades have resulted in increased burden of T2DM coupled with lifestyle changes with major effect of increase in prevalence and impact of T2DM on disability. 4 Studies have linked T2DM with a high burden of physical limitation and functional disability, [5] [6] [7] [8] [9] putting people living with T2DM at risk of disability with about 25.0% being more likely to develop disability than those without. 6 It had been suggested that 6 years after diagnosis of T2DM, 13.6% of patients will develop disability in one activity of daily living (ADL), while 38.3% will develop new functional impairment with an average of 1.0% mean decline in function per year. 5, 8 This may imply that activities such as self-care and mobility/ambulation may decline as the disease progresses if untreated.
Annual work disability rate is reported to be higher among those with T2DM than those without (95 vs. 35 days per year, respectively). 10 Factors reported to cause increased burden of disability among people with T2DM include older age and metabolic syndrome. Being 50 years and above and metabolic syndrome are said to be predictive of impairment of basic ADL, while lower cognitive function, baseline instrumental ADL problems, insulin therapy and physical inactivity were significant predictors of a future decline in ADL. 8 Socio-economic status, obesity and exercise have been shown to explain the association between T2DM and disability. 11 Other factors like gender, racial differences in functional limitations and co-existence of stroke and T2DM are reported to have great impact on disability prevalence. 12, 13 Gender and educational level are reported to affect work disability with the females more at risk. 10 A study by Virtanen et al. of T2DM employees reported 2 distinct groups characterised by high and low prevalence of co-morbid state: alcohol use, obesity, psychological symptoms and physical inactivity. 14 The risk of future work disability is predicted by the prevalence.
Differences linking functional limitation or global disability with T2DM have been reported. 11 This makes accurate estimates of T2DM-associated disability important for their health needs. There is paucity of study on global disability burden in Nigerians with T2DM. Hence, estimating the burden of disability will not only elucidate the magnitude of the problem but also help develop appropriate and targeted screening efforts to reduce societal burden of disability and improve health outcomes for persons with T2DM in Nigeria. This study therefore aimed to determine the prevalence of global disability and its predictors among Nigerians with T2DM.
METHODS

Design and setting
This was a cross-sectional study of people with T2DM attending the outpatient clinic of a University Teaching Hospital. The teaching hospital serves Ogun State and receives referrals from other parts of South Western Nigeria. It provides health care services to about 1 million Nigerians living in Ogun State, Nigeria. It has an outpatient clinic, the Dame Adebutu Diabetes Care Centre (DADCC), which provides health care service for a wide range of endocrine disorders including T2DM.
Population and sample
One hundred and sixty-two adults with T2DM, 21 years and older, attending the outpatient clinic of OOUTH and able to grant an interview were consecutively recruited during the study period (March 2016 to May 2017).
Sample size was determined with the assumption of moderate effect size at significant criterion of 0.05 with the formula N = 8K + 40, where N is the sample size and K is the number of variables. 15 To achieve statistically significant prediction using Poisson regression analysis at α = 0.05 with 10 variables, the calculated sample size is 120: [8 × 10 + 40] .
Assessment of disability
World Health Organization Disability Assessment Schedule (WHODAS 2.0) short form -a five-point ordinal scale ranging from 1 (none) to 5 (extreme or cannot do it) -was used to assess disability among study participants. World Health Organization Disability Assessment Schedule 2.0 provides a common metric for the impact of any health condition in terms of functioning. Being a generic measure, it provides measures for assessing both physical and mental disability burden of all health conditions whatever their cause. 16 Its validation had been discussed in another study. 16, 17 For item-based analysis, each item was dichotomised as no disability (1 = none) and presence of disability: 2-5 (mild to extreme). The items were re-coded into 0 (none) to 4 (extreme or cannot do it) for both simple sum and item-response theory (IRT) summary score analysis. Summary score of 45 was the cut-off point for overall disability. 18 Simple sum norm values of 1-4, 5-9 and 10-48 were used to classify survivors as having mild, moderate and severe disability, respectively. 19 The validity of WHODAS has been reported to be good. 16 Global disability burden is defined operationally as a general reduction in functioning, that is, body function and structure, personal activities and societal participation.
Covariates
A structured questionnaire was used to collect information on socio-demographic parameters with self-reported T2DM duration (in month) obtained from the participants. Standard methods were used to assess blood pressure and body mass index (BMI). The most recent laboratory parameters of fasting blood glucose (FBG) and glycosylated haemoglobin (HbA1c) were extracted from patient's medical records.
Statistical analysis
All data were collated and analysed using Statistical Package for Social Sciences (SPSS) version 16 (SPSS, Chicago, IL).
Continuous and categorical variables were presented as frequency, mean and standard deviation. Significant differences were assessed with chi-squared (χ 2 ) test for categorical variables and Student's t-test or F-test for continuous variables.
Poisson regression analysis was used to determine association or predictive factors of disability. Level of statistical significance had p-values reported as two-sided with predefined p-value set at 0.05.
Ethical consideration
The Health Research Ethics Committee of Olabisi Onabanjo University Teaching Hospital (HREC-OOUTH), Nigeria, approved the study protocol, while all participants gave written informed consent. Clearance number: OOUTH/HREC/40/2016.
RESULTS
One hundred and sixty-two patients with T2DM (male 74; 45.7%) with mean (SD) age 60.2 (13.0) years attending the DADCC of University Teaching Hospital participated in the study. Table 1 shows the prevalence of disability by items. The prevalence of disability was high (50.6% -63.0%) in 3 items and moderate in nine items ranging between 24.7% and 46.9%. However, when summary cut-off score (45) was used; only 12.3% of people with T2DM reported global disability. Adjusted for sex, the pattern of the prevalence was similar as there was no gender difference in the prevalence of disability among the participants (Table 1 ).
The severity of disability among patients with T2DM attending OOUTH is shown in Figure 1 . About a seventh (14.2%) reported no disability, 25.0% had mild disability, while 60.5% reported moderate to severe disability. Although the female participants reported more mild and severe disability than male participants, the difference was not statistically significant. The pattern of disability by socio-demographic and clinical parameters is shown in Table 2 . The disability was 22.1 suggesting mild disability based on International Classification of Functioning, Disability and Health (ICF) severity range.
This decreased with increasing level of education and T2DM duration though not statistically significant. Furthermore, there was no gender difference in the pattern of disability among the study participants (Table 2 ).
Figure 1 Severity of disability in the patients with T2DM
Poisson regression analysis showed both clinical and socio-demographic variables of FBG, glycosylated haemoglobin (HbA1c), elevated systolic blood pressure (SBP), age, T2DM duration and marital status as significant predictors of disability among people with T2DM (Table 3) . With 1-year increase in age and a unit increase in FBG, there was 0.8% and 0.5% decrease in disability, respectively, while a unit increase in HbA1c, SBP and 1 month increase in T2DM duration resulted in an estimated 1.062, 1.005 and 1.001 times, respectively, more disability report. The married participants were 1.13 times more likely to be disabled than unmarried. This is in tandem with previous reports linking T2DM with different measures of disability. [5] [6] [7] [8] [9] Those studies reported higher prevalence of disability (50.0% -80.0%) or risk of developing new disability in terms of functioning after diagnosis of T2DM compared with people without T2DM. It is postulated that untreated hyperglycaemia may activate the inflammatory pathway and lead to loss of muscle mass, strength and efficiency, particularly in the lower extremities, which in turn decrease mobility and participation in routine activities and thus aggravate the onset of global disability. 7 It is therefore appropriate to include measures that reduce global disability in the management of T2DM from onset of diagnosis. This becomes necessary as our finding suggests that 60.5% of T2DM experienced moderate to severe level of disability. Previous study that used the same measure of disability as ours also reported significant number of T2DM with moderate to severe level of global disability of 77.0%. 20 Our study reported mild disability among people with T2DM based on ICF severity range. Studies that used generic measure of disability (WHODAS 2.0) are not available for comparison. However, the mild global disability score (22) in this study is lower than the moderate global disability score (44) reported among Nigerian stroke survivors despite using same assessment measure of global disability. 18 This may suggest that T2DM is associated with less burden of global disability compared with stroke survivors. As our participants are undergoing treatment for glycaemic control, it may also suggest that disability could be avoided or certainly minimised in patients with T2DM if they were to adhere to treatment and health promotion aspects related to their disease. There are studies reporting that people with T2DM who adhered to treatment and lifestyle modification have good clinical outcome. 21, 22 Findings from this study suggest no gender difference in the burden of global disability implying that gender does not predict disability after diagnosis of T2DM. This is similar to that of Sakurai et al., 8 who reported no gender association with functional disability. Therefore, both sexes should be advised on how to reduce disability after diagnosis of T2DM. Some studies tried to explain the link between disability and T2DM based on gender difference with females having worse disability. 11, 23 Sex differences in burden of disability among people with T2DM as reported by previous studies have not been consistent perhaps because of different methods of assessment used. Thus, variation in burden of disability based on gender was reported in physical performance tests, ADL and instrumental ADL. 24 Our findings of elevated HbA1c, FBG, SBP, age, T2DM duration and marital status as significant predictors of disability among people with T2DM suggest the multifactorial nature of disability in T2DM and require integration of many factors (including modifiable risks) to determine its severity. These factors (such as older age, longer duration of diabetes and elevated SBP) impacted functioning, lead to more disability being reported among participants and may consequently affect quality of life. Our result that a unit increase in HbA1c and SBP corresponds to 6.2% and 0.5% respective increase in global disability suggests that people with T2DM, poor BP and glycaemic control are at high risk of burden of global disability. These observations are in agreement with previous report that T2DM with co-morbid conditions and poor glycaemic control (defined by HbA1c ≥ 7.0%) had a higher prevalence of functional disability. 7, 12 Indeed, all patients with T2DM require close monitoring in terms of health education, adjusted lifestyle assistance and lifestyle management to reduce disease burden.
This study suggests an association between duration of DM and burden of global disability. One month increase in DM duration has estimated 1.001 times more disability reported in agreement with previous study which observed an association between duration of DM and functional disability. The reported prevalence of functional disability is said to be increasing by approximately 1.3% every year for T2DM. 7 Sequelae of ageing process are likely to add to the burden of global disability among people with T2DM as suggested by our data. About 50.0% of our study participants are aged (> 60 years) and significantly reported reduction in function. There is a probability of loss of autonomy among the aged who may invariably depend on spouse or family members for ADL.
Our study did not show any effect of obesity on the association between T2DM and global disability similar to the report of Assari et al. 11 though, studies suggest that obesity and overweight may aggravate the link between T2DM and disability. [24] [25] [26] Controlling for BMI explained 38.0% of the risk of disability in women and 16% in men. 24 Attention should therefore be directed at improving modifiable risk factors such as BMI to reduce the burden of global disability. The beneficial impacts of optimising BMI in adults with T2DM on disability later in life are supported by a previous study. 27 Most risk factors in T2DM are modifiable with appropriate treatment, care and support. Effort should therefore be directed at these to avoid or limit disability among people with T2DM.
This study revealed increased global disability among married participants when compared with unmarried (singles, separated or divorce, and widows or widowers) participants. This is surprising as it is expected that being married will afford better support (economical, emotional, physical and psychological) necessitating further study of effect of marital status on global disability.
The strength of this study lies in the use of global disability measure and function, WHODAS, to assess disability among individuals with T2DM in this study makes our findings comparable with other studies both on T2DM and other non-communicable diseases. However, WHODAS has been shown to have good psychometric ability in estimating disability among population with ill health. 16 Our findings being from a tertiary health institution need to be interpreted with caution as it may not be representative of the general population of people with T2DM. Many individuals with T2DM are undiagnosed, walk freely in the community unaware of their health status, while those aware are not clinic or drug compliant, or seek alternative medical treatment.
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CONCLUSION
Nigerians with T2DM exhibit mild to moderate degree and burden of global disability predicted by demographic (age, marital status, disease duration) and clinical (glycaemic and blood pressure control) variables. Interventions are needed to limit future global disability and burden among diabetics above age 50 years.
